Citigroup
CDLX icon

Citigroup’s Cardlytics CDLX Stock Holding History

Citigroup’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– – – 5852
2025
Q4 		– Sell
-11
Closed -$255 – 6110
2025
Q3 		$255 Sell
11
-685
-98% -$11.4K ﹤0.01% 5749
2025
Q2 		$11.4K Sell
696
-27,323
-98% -$472K ﹤0.01% 5165
2025
Q1 		$510K Sell
28,019
-19,715
-41% -$563K ﹤0.01% 3665
2024
Q4 		$1.77M Buy
47,734
+44,781
+1,516% +$1.71M ﹤0.01% 2912
2024
Q3 		$94.5K Buy
2,953
+2,056
+229% +$114K ﹤0.01% 4786
2024
Q2 		$73.7K Buy
897
+190
+27% +$20.5K ﹤0.01% 4364
2024
Q1 		$102K Buy
707
+172
+32% +$14.5K ﹤0.01% 4282
2023
Q4 		$49.3K Buy
535
+518
+3,047% +$52.7K ﹤0.01% 4528
2023
Q3 		$2.79K Sell
17
-1,004
-98% -$130K ﹤0.01% 4874
2023
Q2 		$64.5K Buy
+1,021
New +$61.8K ﹤0.01% 4490
2023
Q1 		– Sell
-104
Closed -$6.01K – 5532
2022
Q4 		$6.01K Sell
104
-29
-22% -$1.79K ﹤0.01% 4993
2022
Q3 		$12K Sell
133
-190
-59% -$27K ﹤0.01% 4922
2022
Q2 		$72K Buy
323
+96
+42% +$32.1K ﹤0.01% 4366
2022
Q1 		$125K Sell
227
-668
-75% -$404K ﹤0.01% 4312
2021
Q4 		$592K Buy
895
+459
+105% +$351K ﹤0.01% 3672
2021
Q3 		$366K Buy
436
+211
+94% +$214K ﹤0.01% 3825
2021
Q2 		$286K Sell
225
-3,334
-94% -$3.76M ﹤0.01% 4047
2021
Q1 		$3.9M Buy
3,559
+1,631
+85% +$2.15M ﹤0.01% 1972
2020
Q4 		$2.75M Buy
1,928
+281
+17% +$300K ﹤0.01% 2557
2020
Q3 		$1.16M Sell
1,647
-465
-22% -$338K ﹤0.01% 3133
2020
Q2 		$1.48M Buy
2,112
+1,609
+320% +$929K ﹤0.01% 3142
2020
Q1 		$176K Buy
503
+142
+39% +$101K ﹤0.01% 4833
2019
Q4 		$227K Buy
361
+189
+110% +$92.4K ﹤0.01% 5083
2019
Q3 		$58K Sell
172
-4
-2% -$1.28K ﹤0.01% 6035
2019
Q2 		$46K Buy
176
+14
+9% +$2.8K ﹤0.01% 6547
2019
Q1 		$26K Buy
162
+6
+4% +$976 ﹤0.01% 6802
2018
Q4 		$17K Sell
156
-8
-5% -$1.35K ﹤0.01% 6942
2018
Q3 		$41K Buy
164
+83
+102% +$17.9K ﹤0.01% 6675
2018
Q2 		$18K Sell
81
-4
-5% -$740 ﹤0.01% 6962
2018
Q1 		$12K Buy
+85
New +$14.4K ﹤0.01% 6966

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup's CDLX Position: Q1 2026 in Review

Citigroup held its Cardlytics (CDLX) position steady in Q1 2026 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5852.

Citigroup first reported a position in CDLX in Q1 2018 and has held it in 30 quarters since. The position peaked at $3.9M in Q1 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Citigroup held 0 shares of Cardlytics worth $1 as of Q1 2026.
  • Citigroup left its Cardlytics share count unchanged in Q1 2026.
  • Cardlytics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5852 holding.
  • Citigroup first reported a position in Cardlytics in Q1 2018 and has held it in 30 quarters since.
  • Citigroup's Cardlytics position peaked at $3.9M in Q1 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.